Li‐Ming Gan

机构：China Geological Survey, Sahlgrenska University Hospital, Shanghai University of Traditional Chinese Medicine, Traditional Chinese Medicine Hospital of Kunshan, Zhongshan Hospital, Luye Pharma (China), University of Gothenburg · ORCID：0000-0003-2933-1404

发表论文 98 篇 · 总被引 5844 次 · h-index 35

代表论文

A mechanistic framework for cardiometabolic and coronary artery diseases (2022 · Nature Cardiovascular Research · 被引 129)
Direct intramyocardial injection of VEGF mRNA in patients undergoing coronary artery bypass grafting (2022 · Molecular Therapy · 被引 98)
VEGFA mRNA for regenerative treatment of heart failure (2021 · Nature Reviews Drug Discovery · 被引 92)
Targeting inflammation for the treatment of Diabetic Kidney Disease: a five-compartment mechanistic model (2022 · BMC Nephrology · 被引 61)
Gentiana scabra Restrains Hepatic Pro-Inflammatory Macrophages to Ameliorate Non-Alcoholic Fatty Liver Disease (2022 · Frontiers in Pharmacology · 被引 17)
SGLT2 inhibition improves coronary flow velocity reserve and contractility: role of glucagon signaling (2024 · Cardiovascular Diabetology · 被引 11)